Temperature fluctuations and humidity help the influenza virus thrive, and bring illness to those suffering from pre-existing ...

Preexisting immunity to the 2009 H1N1 influenza virus provided near-complete protection against severe H5N1 disease and ...

An avian influenza pandemic remains within the realm of possibility. To reduce the risk, we need to engage in a One Health ...

Pediatric and adult patients experienced noninferior and robust immune responses to RIV4, as well as similar safety profiles.

H1N1, a contagious respiratory virus, presents flu-like symptoms including fever, cough, and body aches. Treatment involves ...

As for the clinical presentation, most kids had fever (93%) and seizures (68%). They also had elevated liver enzymes (78%), ...

Mice with a handful of cancerous cells in their lungs experienced a 100-fold increase to this number after being infected ...

A case series describes 41 US children with influenza-related acute necrotizing encephalopathy (ANE) that killed 27% of ...

Studies suggest that people who had seasonal flus or vaccinations have low antibody levels against H5N1 bird flu.

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...

In the United States, influenza vaccine effectiveness (VE) was similar in pregnant and nonpregnant women of reproductive age, ...

Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced a strategic co-marketing agreement with ...